Latest News
|
14 May 2013
0 Likes 
Republican legislators on the House Energy and Commerce Committee announced on 13 May 2013 that they are opening an investigation into the unusual and unexpected departure of one of the US Food and
Read More...
Latest News
|
14 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US US Government Files Morning-After Pill Appeal (AP) (WSJ) (CBS) (The Hill) (SCOTUS Blog)
Read More...
Latest News
|
13 May 2013
0 Likes
As anyone who has ever lost power—be it because of a storm or a blown transformer—can attest, ours is a society that relies heavily on the use of electricity. Everything from our houses to our modes
Read More...
Latest News
|
13 May 2013
0 Likes
The US Department of Justice (DOJ) has announced that Indian generic pharmaceutical manufacturer Ranbaxy has pleaded guilty to three felony charges, including lying to the US Food and Drug
Read More...
Regulatory Update
|
13 May 2013
0 Likes
The Committee on Social Security and Family of Brazil’s House of Representatives held a hearing on 9 May 2013 on the scope of regulatory authority of Brazil’s National Health Surveillance Agency
Read More...
Latest News
|
13 May 2013
1 Likes
The US Food and Drug Administration (FDA) may still be in the midst of figuring out how to overhaul its medical device compliance approach in regards to quality, but a new report out from device
Read More...
Latest News
|
13 May 2013
0 Likes
The US Food and Drug Administration (FDA) has announced that it plans to move forward with a proposed study on direct-to-consumer (DTC) advertising first announced in August 2012 regarding the use of
Read More...
Latest News
|
13 May 2013
0 Likes
In a surprising move, the US Food and Drug Administration (FDA) on 10 May 2013 announced that it would permit generic competition to Endo Pharmaceuticals' generic pain pill Opana ER (oxymorphone
Read More...
Latest News
|
13 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Did FDA Make a Huge Blunder Approving Merck’s Liptruzet? (MPT) (Forbes) (Pharmalot) (Counter:
Read More...
Latest News
|
10 May 2013
0 Likes
Hello and welcome to a new edition of Five in Focus, our Friday recap of the five most important, interesting, riveting or ground-breaking stories of the week.FDA Reaches out to Industry for Help as
Read More...